Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Antidepressant drugs (ADs) have been shown to activate BDNF (brain-derived neurotrophic factor) receptor TrkB in the rodent brain but the mechanism underlying this phenomenon remains unclear. ADs act as monoamine reuptake inhibitors and after prolonged treatments regulate brain bdnf mRNA levels indicating that monoamine-BDNF signaling regulate AD-induced TrkB activation in vivo. However, recent findings demonstrate that Trk receptors can be transactivated independently of their neurotrophin ligands. METHODOLOGY: In this study we examined the role of BDNF, TrkB kinase activity and monoamine reuptake in the AD-induced TrkB activation in vivo and in vitro by employing several transgenic mouse models, cultured neurons and TrkB-expressing cell lines. PRINCIPAL FINDINGS: Using a chemical-genetic TrkB(F616A) mutant and TrkB overexpressing mice, we demonstrate that ADs specifically activate both the maturely and immaturely glycosylated forms of TrkB receptors in the brain in a TrkB kinase dependent manner. However, the tricyclic AD imipramine readily induced the phosphorylation of TrkB receptors in conditional bdnf⁻/⁻ knock-out mice (132.4±8.5% of control; P = 0.01), indicating that BDNF is not required for the TrkB activation. Moreover, using serotonin transporter (SERT) deficient mice and chemical lesions of monoaminergic neurons we show that neither a functional SERT nor monoamines are required for the TrkB phosphorylation response induced by the serotonin selective reuptake inhibitors fluoxetine or citalopram, or norepinephrine selective reuptake inhibitor reboxetine. However, neither ADs nor monoamine transmitters activated TrkB in cultured neurons or cell lines expressing TrkB receptors, arguing that ADs do not directly bind to TrkB. CONCLUSIONS: The present findings suggest that ADs transactivate brain TrkB receptors independently of BDNF and monoamine reuptake blockade and emphasize the need of an intact tissue context for the ability of ADs to induce TrkB activity in brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a study by Rantamaki et al. (2011) showed a rapid action of imipramine on TrkB phosphorylation in either presence or absence of BDNF, suggesting that antidepressants do not require BDNF to activate TrkB, an effect that was independent of 5-HTT.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, the recent data suggesting that antidepressant could also directly transactivated TrkB (Rantamaki et al. 2011) point to this receptor as a main molecular target for treating depression.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the tricyclic antidepressant imipramine (30 mg/kg i.p.) increased phosphorylation of TrkB (residue Y816) 30 minutes post-treatment in the PFC (Rantamäki et al., 2011).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Rantamäki et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“fluoxetine (30 mg/kg i.p.) also increased phosphorylation of TrkB one-hour post-treatment in the hippocampus of WT and serotonin transporter knockout mice”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Rantamäki et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“suggesting that antidepressants do not require BDNF to activate TrkB, an effect that was independent of 5-HTT.”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Rantamaki et al. 2011
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394 · cited 1×
“Brainderived neurotrophic factor (BDNF) is the main endogenous ligand for TrkB [3], but recent evidence demonstrates that TrkB can also be transactivated independently of BDNF or other neurotrophins through neuromodulator receptors [6,7] and small molecules [8,9].”
BackgroundA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“Moreover, chronic, but not acute, AD treatment increases BDNF synthesis in the rodent brain [16,35].”
BackgroundNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“Moreover, chronic, but not acute, AD treatment increases BDNF synthesis in the rodent brain [16,35].”
BackgroundNeurotrophins and Neuronal Plasticity
Thoenen, H. (1995) · Science · doi:10.1126/science.270.5236.593 · Cited by 1,927 · cited 1×
“differentiation, survival and plasticity throughout life [1–5].”
Neurotrophins as synaptic modulators
Poo, M.-M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35049004 · Cited by 1,775 · cited 1×
“differentiation, survival and plasticity throughout life [1–5].”
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356 · cited 1×
“Since it has recently been suggested that pro and mature forms of BDNF might have different capacities to activate TrkB [27], we investigated the effects of acute antidepressant treatment on proBDNF cleavage in brain.”
BackgroundNEUROTROPHINS AND SYNAPTIC PLASTICITY
McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337 · cited 1×
“differentiation, survival and plasticity throughout life [1–5].”
Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232 · cited 1×
“range upon a successful treatment with ADs [18,19].”
BackgroundIncreased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164 · cited 1×
“. Levels of BDNF are reduced in the brain and serum of depressed patients and the levels are returned back to normal range upon a successful treatment with ADs”
Background
Cited by
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.034 · Cited by 663
Self-citationBDNF mediates adaptive brain and body responses to energetic challenges
Marosi, K., & Mattson, M. P. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.10.006 · Cited by 568
“even activate TrkB independent of any effect on BDNF levels [65].”
BackgroundMoylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529
Liu, R.-J., Lee, F. S., Li, X.-Y., Bambico, F., Duman, R. S., & Aghajanian, G. K. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.030 · Cited by 403
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Neuronal plasticity and neurotrophic factors in drug responses
Castrén, E., & Antila, H. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.61 · Cited by 284
Self-citationTrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders
Gupta, V., You, Y., Gupta, V., Klistorner, A., & Graham, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510122 · Cited by 258
“act by upregulating BDNF expression in the brain leading to enhanced TrkB signalling while other studies suggest that antidepressant drugs may also transactivate TrkB receptors in the brain independent of their effects on BDNF expression [141].”
BackgroundThe Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging
Vecchio, L. M., Meng, Y., Xhima, K., Lipsman, N., Hamani, C., & Aubert, I. (2018) · Brain Plasticity · doi:10.3233/bpl-180069 · Cited by 225
Mechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Adachi, N. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i4.409 · Cited by 169
Neurotrophins and Psychiatric Disorders
Castrén, E. (2014) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-45106-5_17 · Cited by 150
Kohtala, S. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00232-4 · Cited by 142
Are BDNF and glucocorticoid activities calibrated?
Jeanneteau, F., & Chao, M. V. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.017 · Cited by 141
“These observations suggest that bdnf is not necessarily required for TrkB activation (Rantamaki et al., 2011).”
Shirayama, Y., Yang, C., Zhang, J.-C., Ren, Q., Yao, W., & Hashimoto, K. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.09.002 · Cited by 137
“, imipramine and fluoxetine) could increase phosphorylation of TrkB in the brain (Rantamäki et al., 2011; Di Lieto et al., 2012).”
Tejeda, G., & Díaz-Guerra, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020268 · Cited by 126
“Brain TrkB transactivation is also achieved by antidepressant drugs in adult mice via unknown mechanisms [16] that result in specific phosphorylation of Tyr816, PLCγ activation and CREB phosphorylation [151], processes that are independent of monoamine transporter inhibition or BDNF action [203].”
BackgroundVGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases
Quinn, J. P., Kandigian, S. E., Trombetta, B. A., Arnold, S. E., & Carlyle, B. C. (2021) · Brain Communications · doi:10.1093/braincomms/fcab261 · Cited by 124
Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth
Ly, C., Greb, A. C., Vargas, M. V., Duim, W. C., Grodzki, A. C. G., Lein, P. J., & Olson, D. E. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00065 · Cited by 123
Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
Zhao, H., Alam, A., San, C.-Y., Eguchi, S., Chen, Q., Lian, Q., & Ma, D. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.029 · Cited by 122
Mice with altered BDNF signaling as models for mood disorders and antidepressant effects
Lindholm, J. S. O., & Castrén, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00143 · Cited by 114
“However, in adult mice, TrkB phosphorylation appears to be only slightly altered, if at all (Rantamäki et al., 2011).”
BackgroundCulturing primary neurons from rat hippocampus and cortex
Sahu, M. P., Nikkilä, O., Lågas, S., Kolehmainen, S., & Castrén, E. (2019) · Neuronal Signaling · doi:10.1042/ns20180207 · Cited by 112
The role of neurotrophins in major depressive disorder
Jiang, C., & Salton, S. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0103-8 · Cited by 113
Furmaga, H., Carreno, F. R., & Frazer, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034844 · Cited by 99
Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists
Boltaev, U., Meyer, Y., Tolibzoda, F., Jacques, T., Gassaway, M., Xu, Q., Wagner, F., Zhang, Y.-L., Palmer, M., Holson, E., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal1670 · Cited by 94
Ubhi, K., Inglis, C., Mante, M., Patrick, C., Adame, A., Spencer, B., Rockenstein, E., May, V., Winkler, J., & Masliah, E. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.008 · Cited by 86
“One possible alternative pathway by which fluoxetine may enhance BDNF expression is via the transactivation of the BDNF receptor TrkB (Rantamaki et al., 2011; Saarelainen et al., 2003; Wyneken et al., 2006) followed by the binding of BDNF to the TrkB receptor resulting in the internalization of the BDNF-TrkB complex w…”
BackgroundIsoflurane produces antidepressant effects and induces TrkB signaling in rodents
Antila, H., Ryazantseva, M., Popova, D., Sipilä, P., Guirado, R., Kohtala, S., Yalcin, I., Lindholm, J., Vesa, L., Sato, V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08166-9 · Cited by 84
Self-citationZinc and the ERK Kinases in the Developing Brain
Nuttall, J. R., & Oteiza, P. I. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9291-6 · Cited by 86
“Like zinc, antidepressants are able to transactivate TrkB independent of neurotrophins (Rantamaki et al. 2011).”
BackgroundLiberto, V. D., Mudò, G., & Belluardo, N. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.018 · Cited by 91
TrkB inhibition as a therapeutic target for CNS-related disorders
Boulle, F., Kenis, G., Cazorla, M., Hamon, M., Steinbusch, H. W. M., Lanfumey, L., & van den Hove, D. L. A. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.002 · Cited by 80
“ylation, independently of BDNF and monoamine transporter blockade in the rat brain (Rantamaki et al., 2011).”
BackgroundiPlasticity: Induced juvenile‐like plasticity in the adult brain as a mechanism of antidepressants
Umemori, J., Winkel, F., Didio, G., Llach Pou, M., & Castrén, E. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12683 · Cited by 80
“For example, AD treatment upregulates the expression of CREB2,208 and CREB overexpression in the rat hippocampus induces an AD-like behavior.209 Evidence for increased BDNF in human patients after chronic AD treatment has also been reported; postmortem tissues had an increased level of BDNF in the hippocampi of depres…”
BackgroundProwse, N. A., & Hayley, S. P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.09.018 · Cited by 78
Thakker-Varia, S., Behnke, J., Doobin, D., Dalal, V., Thakkar, K., Khadim, F., Wilson, E., Palmieri, A., Antila, H., Rantamaki, T., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.03.005 · Cited by 65
“An enzyme-linked immunosorbent assay (ELISA) method was used to measure the level of phosphorylated Trk receptors from primary neurons as described (Rantamaki et al., 2011).”
Self-citationDiniz, C. R. A. F., Casarotto, P. C., Resstel, L., & Joca, S. R. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.001 · Cited by 58
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V. D., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2021) · NORA - Norwegian Open Research Archives · Cited by 61
Self-citation5-HTT independent effects of fluoxetine on neuroplasticity
Levy, M. J. F., Boulle, F., Emerit, M. B., Poilbout, C., Steinbusch, H. W. M., van den Hove, D., Kenis, G., & Lanfumey, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-42775-w · Cited by 64
Neuroprotective Effects of Reactive Oxygen Species Mediated by BDNF-Independent Activation of TrkB
Huang, Y. Z., & McNamara, J. O. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0755-12.2012 · Cited by 56
“, fluoxetine) in vivo (Rantamäki et al., 2011) results in increased p-Trk immunoreactivity at 100 kDa.”
BackgroundMethodColle, R., Deflesselle, E., Martin, S., David, D. J., Hardy, P., Taranu, A., Falissard, B., Verstuyft, C., & Corruble, E. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.56 · Cited by 56
Sharma, V., Singh, T. G., Kaur, A., Mannan, A., & Dhiman, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03755-1 · Cited by 59
Dysregulated copper transport in multiple sclerosis may cause demyelination via astrocytes
Colombo, E., Triolo, D., Bassani, C., Bedogni, F., Di Dario, M., Dina, G., Fredrickx, E., Fermo, I., Martinelli, V., Newcombe, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025804118 · Cited by 52
“…response to stimuli distinct from BDNF. TrkB transactivation independent from neurotrophin binding has been described for neuronal full-length TrkB after exposure to estrogens (27), epidermal growth factor (28), G protein-coupled receptor ligands (29), some metals (30) or antidepressant drugs (31).”
Rantamäki, T., Kemppainen, S., Autio, H., Stavén, S., Koivisto, H., Kojima, M., Antila, H., Miettinen, P. O., Kärkkäinen, E., Karpova, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068722 · Cited by 51
“The generation and validation of this antibody has been characterized in previous publications [38–40].”
MethodSelf-citationThe Monoaminergic Tripartite Synapse: A Putative Target for Currently Available Antidepressant Drugs
Quesseveur, G., Gardier, A., & Guiard, B. (2013) · Current Drug Targets · doi:10.2174/13894501113149990209 · Cited by 51
“Accordingly, as the high affinity receptor of BDNF, TrkB is autophosphorylated in response to the chronic administration of various classes of antidepressant drugs in the mouse HP and cingulate cortex [236, 237], whereas transgenic mice with the non-functional truncated TrkB are less sensitive to these treatments [238…”
BackgroundKohtala, S., Theilmann, W., Suomi, T., Wigren, H.-K., Porkka-Heiskanen, T., Elo, L. L., Rokka, A., & Rantamäki, T. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00002 · Cited by 51
Self-citationAntidepressant drug action--From rapid changes on network function to network rewiring
Rantamäki, T., & Yalcin, I. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.001 · Cited by 50
Self-citationGong, W.-G., Wang, Y., Zhou, H., Li, X.-L., Bai, F., Ren, Q., & Zhang, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9781-x · Cited by 49
“Some researches have demonstrated that escitalopram treatment could increase BDNF mRNA and protein levels, as well as TrkB (the primary receptor for BDNF) mRNA levels in postnatal day 13 pups as compared to control [68], and citalopram could activate TrkB in TrkB mutant and TrkB-overexpressing mice [69].”
Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice
Zhang, S.-S., Tian, Y.-H., Jin, S.-J., Wang, W.-C., Zhao, J.-X., Si, X.-M., Zhang, L., Xu, H., & Jin, J.-Y. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05287-z · Cited by 49
“However, it is also reported that rapid activation of TrkB in response to antidepressants administration in vivo does not require BDNF release (Rantamaki et al. 2011).”
BackgroundAcetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus
Autio, H., Mätlik, K., Rantamäki, T., Lindemann, L., Hoener, M. C., Chao, M., Arumäe, U., & Castrén, E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.033 · Cited by 46
“…with our observations that while antidepressant drugs activate the autophosphorylation of TrkB when administered to mice in vivo (Saarelainen et al., 2003; Rantamäki et al., 2007) these drugs do not activate TrkB receptors in cultured hippocampal or cortical neurons (Rantamäki et al., 2011).”
BackgroundSelf-citationBDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions
Cubillos, S., Engmann, O., & Brancato, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214445 · Cited by 47
“The effects of monoaminergic antidepressants and ketamine on TrkB signaling have long been considered indirect, caused by the inhibition of monoamine transporters and NMDA receptors, respectively, and mediated by the increase in BDNF expression and release [19].”
BackgroundDi Lieto, A., Rantamäki, T., Vesa, L., Yanpallewar, S., Antila, H., Lindholm, J., Rios, M., Tessarollo, L., & Castrén, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032869 · Cited by 47
“Furthermore, as already reported in adult brain [9,18], acute treatment with IMI did not regulate total protein levels of TrkB at any age (data not shown).”
InfluentialSelf-citationRantamäki, T., & Kohtala, S. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018697 · Cited by 45
“Rapid-acting antidepressants alleviate depression within hours, indicating that their mode of action is fundamentally different from conventional antidepressants, although the treatments trigger several shared molecular pathways (Rantamäki et al., 2007, 2011; Rantamäki, 2019).”
BackgroundSelf-citationTrkB neurotrophin receptor at the core of antidepressant effects, but how?
Rantamäki, T. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-02985-6 · Cited by 45
Self-citationThe antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF
Scabia, G., Barone, I., Mainardi, M., Ceccarini, G., Scali, M., Buzzigoli, E., Dattilo, A., Vitti, P., Gastaldelli, A., Santini, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19886-x · Cited by 54
“2-way ANOVA (stimulus effect, F(1,34) = 77.”
Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice
Burke, T. F., Advani, T., Adachi, M., Monteggia, L. M., & Hensler, J. G. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000466 · Cited by 42
“Antidepressantinduced TrkB phosphorylation does not occur in cultured neurons or cells expressing TrkB, suggesting that intact tissue is necessary (Rantamäki et al. 2011).”
BackgroundCollier, T. J., Srivastava, K. R., Justman, C., Grammatopoulous, T., Hutter-Paier, B., Prokesch, M., Havas, D., Rochet, J.-C., Liu, F., Jock, K., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.007 · Cited by 41
Koskimäki, J., Matsui, N., Umemori, J., Rantamäki, T., & Ċastrén, E. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0110-5 · Cited by 37
“calcium channel blockers have been shown to block activity-dependent BDNF synthesis, our recent data support a BDNF-independent mechanism underlying rapid antidepressant-induced TrkB activation (Zafra et al. 1990; Poulsen et al. 2004; Rantamäki et al. 2011).”
BackgroundResultInfluentialSelf-citationShah, A. P., Carreno, F. R., Wu, H., Chung, Y. A., & Frazer, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.024 · Cited by 38
“As mentioned, AD drugs activate TrkB by phosphorylation at tyrosine residue 705 (Y705), within the autophosphorylation catalytic domain of TrkB and also at tyrosine residue 816 (Y816), which leads to activation of the phospholipase C-gamma1 (PLC-c1) pathway (Saarelainen et al., 2003; Rantamaki et al., 2007; Furmaga et…”
BackgroundResultInfluentialAkhter, E. T., Griffith, R. W., ENGLISH, A. W., & Álvarez, F. J. (2019) · eNeuro · doi:10.1523/eneuro.0172-19.2019 · Cited by 33
“1NMPP1 was administered in the drinking water using established protocols that prevent TrkB downstream signaling (Chen et al., 2005; Wang et al., 2009; Rantamäk et al., 2011).”
MethodMalki, K., Lourdusamy, A., Binder, E., Paya-Cano, J. L., Sluyter, F., Craig, I., Keers, R., McGuffin, P., Uher, R., & Schalkwyk, L. C. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328356fa90 · Cited by 35
Wang, W., Kantorovich, S., Babayan, A. H., Hou, B., Gall, C. M., & LYNCH, G. S. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.83 · Cited by 37
Anderzhanova, E., Hafner, K., Genewsky, A. J., Soliman, A., Pöhlmann, M. L., Schmidt, M. V., Blum, R., Wotjak, C. T., & Gassen, N. C. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100239 · Cited by 29
The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder
Amidfar, M., Réus, G. Z., de Moura, A. B., Quevedo, J., & Kim, Y. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_14 · Cited by 34
Borroto‐Escuela, D. O., Ambrogini, P., Narváez, M., Liberto, V. D., Beggiato, S., Ferraro, L., Fores‐Pons, R., Alvarez‐Contino, J. E., López‐Salas, A., Mudò, G., et al. (2021) · Cells · doi:10.3390/cells10081902 · Cited by 30
“[63] found that antidepressant drugs such as imipramine can transactivate the TrkB receptor in the rodent brain independently of BDNF and blockade of monoamine transporters.”
BackgroundKarpova, N. N., Lindholm, J., Kulesskaya, N., Onishchenko, N. R., Vahter, M., Popova, D., Ceccatelli, S., & Ċastrén, E. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00315 · Cited by 30
“Different antidepressant drugs activate TrkB receptor independently of Bdnf (Rantamäki et al., 2011) suggesting an antidepressant effect of increased TrkB activity.”
BackgroundLuberg, K., Park, R., Aleksejeva, E., & Timmusk, T. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0215-x · Cited by 31
“In addition, several neurotrophin independent signaling events have been described, including transactivation of receptor tyrosine kinases by adenosine 2A receptors [9, 10], pituitary adenylate cyclase-activating polypeptide receptor [11], low-density lipoprotein receptor-related protein 1 [12], epidermal growth facto…”
BackgroundHeterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Suseelan, S., & Pinna, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.09.001 · Cited by 33
Sakata, K., Mastin, J. R., Duke, S. M., Vail, M. G., Overacre-Delgoffe, A. E., Dong, B. E., & Jha, S. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12148 · Cited by 29
“…may occur without increased BDNF expression but involve activation of its receptor, TrkB. Castren’s group have shown that acute antidepressant treatment increases the phosphorylation of TrkB in 30 min (Rantamaki et al., 2011) without increasing BDNF levels in the HIP (Rantamaki et al., 2007).”
BackgroundAonurm‐Helm, A., Jaako, K., Jürgenson, M., & Zharkovsky, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.011 · Cited by 30
Dual mechanism of TRKB activation by anandamide through CB1 and TRPV1 receptors
Diniz, C. R. A. F., Biojone, C., Joca, S. R. L., Rantamäki, T., Ċastrén, E., Guimarães, F. S., & Casarotto, P. C. (2019) · PeerJ · doi:10.7717/peerj.6493 · Cited by 29
Self-citationNeurotrophin Genes and Antidepressant-Worsening Suicidal Ideation: A Prospective Case-Control Study
Voegeli, G., Ramoz, N., Shekhtman, T., Courtet, P., Gorwood, P. A. P. M., & Kelsoe, J. R. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw059 · Cited by 24
Vakhitova, Y. V., Kalinina, T. S., Zainullina, L. F., Lusta, A. Y., Volkova, A. V., Kudryashov, N. V., Gudasheva, T. A., Shimshirt, A. A., Kadnikov, I. A., Voronin, M. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413381 · Cited by 21
“[19,20] have demonstrated that, unlike BDNF, which requires prolonged administration of antidepressants to get a level increase, activation of the TrkB receptor in the cortex and hippocampus can occur upon even acute”
BackgroundSteinzeig, A., Cannarozzo, C., & Ċastrén, E. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14512 · Cited by 25
“…by Federation of European Neuroscience Societies and John Wiley & Sons Ltd. 3664 | STEINZEIG ET al. receptor TrkB (Björkholm & Monteggia, 2016; Duman & Monteggia, 2006; Nibuya, Morinobu, & Duman, 1995; Saarelainen et al., 2003), independently from serotonin transporter (Rantamäki et al., 2011).”
BackgroundTanuma, M., Kasai, A., Bando, K., Kotoku, N., Harada, K., Minoshima, M., Higashino, K., Kimishima, A., Arai, M., Ago, Y., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133348 · Cited by 21
“SSRIs are also reported to have clinically relevant actions independent of SERT, such as by activating tropomyosin receptor kinase B (TrkB), a receptor for the brain-derived neurotrophic factor (35).”
BackgroundThe multifaceted effects of fluoxetine treatment on cognitive functions
Ampuero, E., Luarte, A., Flores, F. S., Soto, A. I., Pino, C. H., Silva, V., Erlandsen, M., Concha, T., & Wyneken, Ú. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1412420 · Cited by 26
Receptor-Independent Anti-Ferroptotic Activity of TrkB Modulators
Jakaria, M., Belaidi, A. A., Southon, A. G., Dent, K. A., Lane, D. J. R., Bush, A. I., & Ayton, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416205 · Cited by 18
“Antidepressants such as phenelzine transactivate the TrkB receptor independently of BDNF and monoamine transporter blockade in mouse brains [35].”
BackgroundUtilization of in situ ELISA method for examining Trk receptor phosphorylation in cultured cells
Antila, H., Autio, H., Turunen, L., Harju, K., Tammela, P., Wennerberg, K., Yli‐Kauhaluoma, J. T., Huttunen, H. J., Ċastrén, E., & Rantamäki, T. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.11.001 · Cited by 20
“The Spectrum Collection compounds was purchased from MicroSource Discovery Systems, Inc. (Gaylordsville, CT, USA) and stored at -80°C in DMSO stocks of 20 mM.”
MethodSelf-citationPytka, K., Młyniec, K., Podkowa, K., Podkowa, A., Jakubczyk, M., Żmudzka, E., Lustyk, K., Sapa, J., & Filipek, B. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.01.026 · Cited by 19
Orciani, C., Hall, H., Pentz, R., Foret, M. K., Carmo, S. D., & Cuello, A. C. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15683 · Cited by 17
“This could be explained by the known ligand promiscuity of TrkB receptors that, besides BDNF, could be activated by NT- 4/5 (Bothwell, 1995); in addition, TrkB could be activated by BDNFindependent transactivating mechanisms (Di Lieto et al., 2012; Rantamäki et al., 2011).”
BackgroundCasarotto, P. C., Santos, P., Lucas, G., Biojone, C., Pobbe, R. L. H., Vilela‐Costa, H. H., Joca, S. R. L., Guimarães, F. S., & Zangrossi, H. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.03.004 · Cited by 16
“Given evidence that acute AD treatment increases phosphorylation of CREB, a critical upstream regulator of BDNF synthesis in a TRKB dependent manner, Rantamaki et al. (2011) suggest that this ligand-independent TRKB activation contributes to the AD-induced increase in BDNF synthesis, which results…”
Riggs, L. M., Pereira, E. F. R., Thompson, S. M., & Gould, T. D. (2023) · Journal of Neurophysiology · doi:10.1152/jn.00326.2023 · Cited by 15
Межлумян, А. Г., Таллерова, А. В., Povarnina, P. Y., Тарасюк, А. В., Sazonova, N. M., Гудашева, Т. А., & Середенин, С. Б. (2022) · Pharmaceuticals · doi:10.3390/ph15030284 · Cited by 16
Martins, G. M. D. M., Petersen, B. D., Rübensam, G., da Silva, J. M. K., Gaspary, K. V., Wiprich, M. T., Altenhofen, S., & Bonan, C. D. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173455 · Cited by 16
Linking Hypothermia and Altered Metabolism with TrkB Activation
Alitalo, O., González-Hernández, G., Rosenholm, M., Kohtala, P., Matsui, N., Müller, H. K., Theilmann, W., Klein, A. B., Kärkkäinen, O. K., Rozov, S. V., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00350 · Cited by 11
Self-citationHormonal Regulation of Hippocampal Neurogenesis: Implications for Depression and Exercise
Gheorghe, A., Qiu, W., & Galea, L. A. M. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_62 · Cited by 15
Prowse, N. A., Dwyer, Z., Thompson, A., Fortin, T., Elson, K. I., Robeson, H., Fenner, B. M., & Hayley, S. P. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112260 · Cited by 14
Theilmann, W., Alitalo, O., Yorke, I., & Rantamäki, T. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.11.018 · Cited by 14
“Indeed, while ketamine is thought to regulate TrkB signaling through BDNF dependent mechanism [10] the precise mechanism underlying the effects of classical antidepressants and isoflurane remain poorly understood but seems not to involve BDNF [11,31,36].”
InfluentialSelf-citationAlitalo, O., Kohtala, S., Rosenholm, M., Saarreharju, R., González-Hernández, G., Sarparanta, M. P., Rozov, S. V., & Rantamäki, T. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110172 · Cited by 11
Self-citationAonurm‐Helm, A., Anier, K., Zharkovsky, T., Ċastrén, E., Rantamäki, T., Stepanov, V., Järv, J., & Zharkovsky, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.001 · Cited by 11
Self-citationJian-rong, G., Wang, H., Tao, Q., Sun, S., Liu, L., Zhang, J., & Yang, D. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26051 · Cited by 8
“…of tricyclic antidepressants, such as amitriptyline and imipramine (Ip), were identified to have neurotrophic effect by activating tropomyosin-receptor-kinase (Trk) receptors, including TrkA, TrkB, or TrkC [Saarelainen et al., 2003; Jang et al., 2009; Rantamaki et al., 2011; Zheng et al., 2016].”
BackgroundResultInfluentialFacilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21
Laukkanen, L., Diniz, C. R. A. F., Foulquier, S., Prickaerts, J., Ċastrén, E., & Casarotto, P. C. (2021) · Pharmaceuticals · doi:10.3390/ph14080773 · Cited by 7
“The signal of pTRKB was determined by ELISA [18,23,44].”
MethodInfluentialCampos‐Cardoso, R., da Silva, C. B. P., Carolino, R. O. G., Anselmo-Franci, J. A., Tirapelli, C. R., & Padovan, C. M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113295 · Cited by 10
Kruk, J. S., Vasefi, M., Gondora, N., Ahmed, N., Heikkila, J. J., & Beazely, M. A. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.02.013 · Cited by 8
“…as GPCR agonists or that activate GPCRs in addition to their primary target, such as SSRIs, are generally not subject to rapid clearancemechanisms, and thereforemay induce transactivation signaling to growth factor receptors such as PDGF receptors and TrkB receptors (Rantamaki et al., 2011).”
BackgroundMartin, K. K., Noble, D. J., Parvin, S., Jang, K., & Garraway, S. M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.987236 · Cited by 8
“Comparable procedures for pharmacogenetic inhibition of TrkB signaling by 1NMP administration have been previously reported (e.g., Wang et al., 2009; Rantamäki et al., 2011; Akhter et al., 2019).”
MethodTRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine
Fred, S. M., Moliner, R., Antila, H., Engelhardt, K., Schlüter, O. M., Casarotto, P. C., & Ċastrén, E. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15952 · Cited by 7
“However, the monoaminergic hypothesis has been constantly supplemented by and sometimes conflicted with new evidence suggesting that other systems and receptors are important to understand the role of neurotrophic factors and synaptic plasticity in the process (Altar, 1999; Casarotto et al., 2021; Duman et al., 1997;…”
BackgroundSelf-citationEgzersiz-Kaynaklı BDNF'nin Mental Sağlık Üzerindeki Etkisinin Değerlendirilmesi: Sistematik Derleme
Bırıncı, Y. Z., Sağdilek, E., & ŞAHİN, Ş. (2023) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1223655 · Cited by 5
The neurotoxicity of iodoacetic acid, a byproduct of drinking water disinfection
Wang, X., Rong, C., Niu, P., Leng, W., Wang, G., He, Z., Qi, X., Zhao, D., & Li, J. (2025) · Frontiers in Toxicology · doi:10.3389/ftox.2025.1543374 · Cited by 5
Иродионовна, В. Т., Ахапкин, Р. В., & Aleksandrovsky, Y. A. (2019) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn1107 · Cited by 5
Neuroprotective roles of neurotrophic growth factors in mood disorders
Jiang, C. S., & Salton, S. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00010-0 · Cited by 4
Zetterström, T., Coppell, A., & Khundakar, A. A. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12153 · Cited by 4
“It is, however, unlikely that this effect is related to the fluoxetine-induced inhibition of bdnf in this study; thus, the transient action on TrkB phosphorylation has recently been reported to be independent of 5-HT transporter blockade, as well as BDNF signalling.([44]) As shown previously, twice-daily injections of…”
BackgroundAntidepressant drugs act by directly binding to TRKB neurotrophin receptorsPreprint
Casarotto, P. C., Girych, M., Fred, S. M., Kovaleva, V. D., Moliner, R., Enkavi, G., Biojone, C., Cannarozzo, C., Sahu, M. P., Kaurinkoski, K., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/757989 · Cited by 5
Self-citationEpigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders
Boulle, F. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20131129fb · Cited by 8
Effects of heat environments on depressive disorders: Neurogenesis-mediated mechanisms
Kong, M.-H., Li, Q., & Chen, X. (2025) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2025.104304 · Cited by 3
Metadata
- Authors
- Rantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E.
- Affiliations
- University of Helsinki (FI)
- University of Würzburg (DE)
- Tufts University (US)
- Corresponding author
- Rantamäki, Tomi
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-06-07
- Volume
- 6
- Issue
- 6
- Pages
- e20567
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3110188
- OpenAlex
- W2019787596
- Cited by
- 124
- References
- 49
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 11 · 2021: 14 · 2020: 7 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 7 · 2013: 11 · 2012: 11
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
- Funders
- Helsingin Yliopisto
- Deutsche Forschungsgemeinschaft
- Suomen Kulttuurirahasto
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- antidepressants, TrkB receptor, brain-derived neurotrophic factor, receptor transactivation, monoamine reuptake inhibitors, serotonin transporter, imipramine, fluoxetine, citalopram, reboxetine, monoamine signaling, antidepressant mechanism
- MeSH terms
- Aging, Amitriptyline, Animals, Antidepressive Agents, Brain, Glycosylation, Imipramine, Mice, Inbred C57BL, Phosphorylation, Transcriptional Activation, Brain-Derived Neurotrophic Factor, Receptor, trkB, Serotonin Plasma Membrane Transport Proteins, Vesicular Monoamine Transport Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.